Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Drugs Genomic-DNA-encoding-the-pseudomonas-fluorescens-alternative-sigma-factor-RpoS-capable-of-activating-gene-expression

 Genomic DNA encoding the pseudomonas fluorescens alternative sigma factor, RpoS, capable of activating gene expression

Details
Inventors: Gaffney, Thomas D.; Lam, Stephen T.;
Assignee: Novartis Finance Corporation (New York, NY)
Primary Examiner: Wax; Robert A.
Assistant Examiner: Moore; William W.
Attorney, Agent or Firm: Meigs; J. Timothy

Gene activating sequences which activate the expression of other bacterial genes, which are latent or expressed at low levels, are provided. The gene activating sequences confer the ability to produce several metabolites and may be transferred to bacterial strains. The transformed biocontrol agents are active to inhibit the growth of the fungal pathogens.

DETAILED DESCRIPTION OF THE INVENTION Pseudomonas fluorescens strain 915 was isolated from the roots of a cotton plant grown in a Texas cotton field and was identified as an effective biocontrol strain of Pythium ultimum- and Rhizoctonia solani-induced damping off of cotton.
We have determined that certain mutant derivatives of the bacterial biological control strain Pseudomonas fluorescens strain 915 are deficient or altered in a variety of functions.
Such pleiotropic mutants can be isolated following mutagenesis techniques known to those skilled in the art (e.
g.
nitrosoguanidine mutagenesis, transposon mutagenesis) or can arise spontaneously.
One such mutant, obtain after mutagenesis with the chemical mutagen nitrosoguanidine was designated mutant 2-1.
Seven further mutants were identified by introducing the transposon TnCIB116 into strain 915.
These mutants can be identified on the basis of their inability to inhibit in vitro the growth of the phytopathogenic fungus Rhizoctonia solani.
They also fail to synthesize the antifungal metabolite pyrrolnitrin, and no longer produce cyanide or the enzyme chitinase, each of which has the potential to inhibit fungal growth (Voisard et al.
, EMBO J.
8:351-358 (1989); Jones et al.
, EMBO J.
5:467-473 (1986)).
The mutants' production of an enzyme with gelatinase activity is significantly reduced, and they have an altered colony morphology.
A summary comparing the characteristics of the pleiotropic mutants with the corresponding characteristics of wild-type P.
fluorescens strain 915 is presented in Table 1.

TABLE 1
______________________________________
Characteristic
P.
fluorescens strain 915
Pleiotropic mutants
______________________________________
Pyrrolnitrin + -
Cyanide + -
Chitinase + -
Gelatinase + reduced
Colony morphology
circular, entire,
circular, undulate,
convex and opaque
flat and translucent
Inhibition of Rhizoctonia
+ -
solani
______________________________________
A total of eight pleiotropic mutants was identified



Related patents
  DNA encoding 5-HT.sub.4 serotonin receptors and uses thereof
OF THE INVENTION This invention provides an isolated nucleic acid molecule encoding a mammalian 5-HT.sub.4 receptor. This invention further provides an isolated nucleic ...
  Cloned DNA encoding a UDP-GalNAc: polypeptide N-acetylgalactosaminy-ltransferase
The present invention is based upon the discoveries of the gene coding for the enzyme N-acetylgalactosaminyltransferase, the amino acid sequence of the enzyme N-...
  DNA comprising regulatory regions from gene y of penicillium chrysogenum
What is claimed is: 1. An isolated DNA comprising a nucleotide sequence obtainable from gene Y which regulates transcription initiation of a DNA sequence of interest ...
  High molecular weight collagen-like protein polymers
What is claimed is: 1. An unnatural collagen-like polymer of at least about 30 kD, characterized by: being capable of being expressed in a unicellular organism from a ...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved